Increlex: Transforming Treatment for Growth Failures

Increlex is a growth hormone therapy containing mecasermin, used for treating growth failure in children with severe primary insulin-like growth factor-1 deficiency. Administered via subcutaneous injection, it stimulates bone and tissue growth, requiring careful medical supervision to manage potential side effects like hypoglycemia. Regular monitoring ensures effective treatment.

Left Menu Icon
Your Cart